Injuries
📧 Sign up to get email alerts when something new happens for Injuries.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: The Use of Public Messaging for the Promotion of Firearm Safety to Veterans [NA]
A completed clinical trial evaluating public messaging to promote firearm safety among veterans; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Preventing Youth Soccer Injury [NA]
A completed clinical trial conducted by the University of Alabama at Birmingham focused on preventing injuries in youth soccer, with results…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Randomized Double Blind Controlled Trial Comparing a Blind Sciatic Nerve Block in the Popliteal Fossa to Intravenous Morphine for Traumatic Severe Acute Pain in the Prehospital Setting [Phase 3]
Phase 3 randomized trial comparing a blind sciatic nerve block in the popliteal fossa to intravenous morphine for traumatic severe acute pai…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement [Phase 2]
Phase 2 single-centre trial investigating safety and efficacy of Tri-Solfen in wound debridement.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Evaluation of Trauma Team Activation Criteria
A completed clinical trial evaluating criteria for Trauma Team Activation has finished enrollment and analysis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions [Phase 3]
Phase 3 trial evaluating the MySkin Patch for healing cut injuries and abrasions has completed, assessing its efficacy in wound healing.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Low Dose Vasopressin in Traumatic Shock [EARLY_Phase 1]
Early-phase trial investigating low-dose vasopressin for traumatic shock has been terminated with results posted.